Orthopedic Study of the Aircast StabilAir Wrist Fracture Brace
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | December 21, 2007 | ||||
| Last Updated Date | October 23, 2012 | ||||
| Start Date ICMJE | April 2006 | ||||
| Primary Completion Date | August 2008 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
To obtain clinical evidence for the safety and efficacy in using the StabilAir Wrist Fracture Brace for the following cases: 1) Acute (emergency department) treatment of non-displaced, stable extra-articular distal radius fractures; [ Time Frame: 6 weeks; 3, 12 and 24 months ] [ Designated as safety issue: No ] | ||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT00587795 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
To obtain comparative data between traditional therapies and the use of the StabilAir brace for each patient qualified by specific criteria. This will provide a complete cost-of-care analysis from one modality to the other. [ Time Frame: 6 weeks; 3, 12 and 24 months ] [ Designated as safety issue: No ] | ||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Orthopedic Study of the Aircast StabilAir Wrist Fracture Brace | ||||
| Official Title ICMJE | Orthopedic Study of the Aircast StabilAir Wrist Fracture Brace | ||||
| Brief Summary | Objectives: - To obtain clinical evidence for the safety and efficacy in using the StabilAir Wrist Fracture Brace for the following cases:
This will provide a complete cost-of-care analysis from one modality to the other. Hypothesis: 1) For stable, non-displaced fractures, the StabilAir Brace is as effective as a sugar tong splint in the acute setting. 2) In cases where full forearm immobilization is initially preferred, the StabilAir is effective as a follow-up to sugar tong splitting once the need for full immobilization has passed. The benefit of utilizing a product of this type in the acute or follow-up setting is that it is an adjustable fit, "off-the-shelf" device, which can be quickly and comfortably applied to the patient. It can then transition effectively to be the product of choice for the remainder of treatment through rehabilitation since it will protect, stabilize, and support the injury while adapting to changing patient conditions and needs. Because it is removable (late but not early in fracture core period) there are potential benefits to comfort and hygiene. Therefore, the total cost of care is reduced by using one product from the progress of the injury to fracture reduction and through to recovery (rather than a variety of products that require investment in materials, time, and personnel for cast changes and potential fracture re-reduction. In the initial treatment period, the StabilAir Brace will be firmly held in place by a peripheral "guard wrap" and will only be removed under the supervision of the treating surgeon. Only when clear evidence of fracture healing is present would the patient be allowed to physically remove the brace. |
||||
| Detailed Description | Data Collection and Study Design: This will be a single center, prospective, randomized controlled trial. We will collect data from 80 patients with undisplaced distal radius fractures. Half will be treated with the plastic back slab or sugar tong splint (if there is ulnar styloid fracture) and half will be treated with the StabilAir splint. The initial treatment, which occurs upon the patient's arrival at the emergency room and prior to study randomization, will require full forearm and wrist immobilization in the acute phase treated with sugar tong splinting. At the patient's follow-up visit, which will happen ≤10 days post injury and initial evaluation, when it is determined that full forearm immobilization is no longer necessary, patients will be informed of the study, consented, and randomized (as in the flip of a coin) to one of the two study groups using a computerized randomization process that will be controlled by the study coordinator. One study group will consist of patients that are treated with either sugar tong splint or plaster casting and the other study group will consist of patients treated with the StabilAir brace. Throughout entire study, the sugar tong splint/casting patients will be the control group. Patients will be asked to return for the following visits after they are randomized:
The decision for treatment will be made using the LaFontaine criteria. If there is a combination of 3 or less LaFontaine criteria (displacement, comminution, distal radio-ulnar joint injury, age >60 years), and no intra-articular involvement, then the patient fits criteria for inclusion. Exclusion criteria include intra-articular fractures, excessive comminution, open fractures, and failed closed reduction of the fracture requiring open reduction. Patients with loss of reduction requiring secondary treatment will be excluded. Assessment of Results: The results of treatment will be assessed by clinical, radiographic and patient assessment criteria. Clinical objective assessment will be performed by the Gartland-Werley score and Mayo Wrist Score. Radiographic assessments were made by the Stewart Score and measures of dorsal angulation, radial shortening, radio-ulnar test. Functional scores will include the DASH (disabilities arm, shoulder, hand) and PRWE (patient related wrist evaluation). Acute Care (ED) Nondisplaced and/or No Forearm Immobilization Required Outcome Measurements:
Materials:
Patient Inclusion Criteria:
Patient Exclusion Criteria:
Tabular format to show:
Discussion: Do the results agree with or support the hypothesis? Is there a clear difference between treatment types? Is there potential for loss of reduction quotes with use of an aircast brace? Is there a greater number of patients converted over from standard cast or sugar tong splint treatment to ORIF vs external fixation (assuming similar fracture stability criteria) in compression to the Aircast Stabilair Brace? Positive feedback indicating benefits to patient's clinical outcome and level of comfort and hand functional use comparing cast treatment vs bracing. |
||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Not Provided | ||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
||||
| Condition ICMJE | Radius Fractures | ||||
| Intervention ICMJE |
|
||||
| Study Arm (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 80 | ||||
| Completion Date | November 2008 | ||||
| Primary Completion Date | August 2008 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | United States | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00587795 | ||||
| Other Study ID Numbers ICMJE | 228-06, StabilAir Wrist Orthosis | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | David Dennison, Mayo Clinic | ||||
| Study Sponsor ICMJE | Mayo Clinic | ||||
| Collaborators ICMJE | AirCast LLC | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Mayo Clinic | ||||
| Verification Date | April 2012 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||